Showing posts with label Diabetes. Show all posts
Showing posts with label Diabetes. Show all posts

Saturday, July 30, 2016

Diabetes is no laughing matter, say young sufferers



Madeline Milzark
Image captionMadeline Milzark told the BBC that the response to her campaign has been 'so heart warming'
A young American woman, infuriated by a social media trend where pictures of cakes and sweets are accompanied by #diabetes, has spelled out what it is really like to have the condition.
On a Facebook post with the hashtag #WhatDiabetesReallyLooksLike, Madeline Milzark, 18, wrote about living with type 1 diabetes.
"Diabetes isn't your piece of cake, or that super-sized McDonald's meal with extra fries or anything you see coated with sugar.
"Diabetes is an 18-year-old girl sitting on her bathroom floor shaking and not able to breathe because her blood sugar dropped and praying her grandma's phone is near her and she got the text message to bring some sugar since she's too weak to yell and the whole room is spinning."
Her post has been shared thousands of times around the world.
Amy BlackImage copyrightMICHAEL BURCH
Image captionAmy Black, who supports Madeline's campaign, said people 'poke fun' at her illness
Madeline told the BBC: "I originally posted the piece because I had low blood sugar, and I finally had enough. So many people post jokes about my disease, even people on my 'friends' list, yet they don't see me when I'm unconscious or when sugar actually saves my life.
"I'm so extremely happy about the response I've gotten.
"I've had so many people telling me I'm making a difference, sharing their stories with me and thanking me. It's so heart-warming."
Like Madeline, Amy Black - from Belfast - has type 1 diabetes and she supports her campaign: "I agree with it in terms of how she's retaliated. It's something which I've experienced personally and frustrates me a lot. A lot of people trivialise diabetes and don't realise how serious it is.
"People don't seem to see it as a chronic illness - people poke fun at it.
"There's a lot of misinformation and confusion between type 1 and type 2.

Type 1 diabetes

  • Around 10% of the 3.5 million people with diabetes have type 1
  • It is most commonly diagnosed in childhood and is not linked to a poor diet or unhealthy lifestyle
  • It is treated with daily doses of the hormone insulin
  • People with the condition have to manage their blood glucose levels in order to do the job that the pancreas is not doing
  • Hypoglycaemia - where blood sugar is too low and there is too much insulin in the blood - can cause shaking, sweating and dizziness or even loss of consciousness
  • People need to eat something containing carbohydrate to bring their blood glucose levels back to normal
  • Hyperglycaemia - where blood glucose is too high - doesn't carry the same immediate risks but can increase the chance of developing complications
  • For more information, go to Diabetes UK or the Juvenile Diabetes Research Foundation

"There have been times where I've been near people buying ice cream or sweets and people have said that they're 'getting diabetes'.
"I never say anything but it makes me feel irritated. It's so frustrating.
"Sometimes people seem to think I was using it as an excuse, because I don't 'look diabetic'. People think you have to be overweight and over 50 but that's simply not the case. There needs to be more public education."

Online support

Amy was 11 when she was diagnosed. A boy at school had recently found out he had the condition and described his symptoms to the class - increased thirst, going to the toilet more, feeling more tired and growing thinner. These are known as the four Ts of type 1 diabetes.
When she started experiencing her symptoms a few months later her mother, who was a nurse, tested her blood.
Now she says stress makes her condition worse, and she has had seizures in her sleep. She constantly has to keep an eye on her blood sugar levels.
Sophie Lane has recently started a blog describing her life with type 1 diabetes .
The 24-year-old says people are not aware of what having the condition involves.
"I find it hard when I'm doing an injection. I don't want to move away to do it but people keep asking questions about why I have to do it."
Sophie LaneImage copyrightOTHER
Image captionSophie Lane uses social media to make contact with others who have type 1
Sophie was 12 when she was diagnosed and says: "I was lucky. I had very mild symptoms. My GP was diabetic and she spotted the symptoms."
Despite her symptoms being relatively mild, she was sent to hospital.
Sophie, from Hertfordshire, is now using social media to connect with other people with the condition and find support through her blog and an Instagram account.
"On your own, it's harder but when people have the same issues as you have, it helps," she says.
"It helped me so much. The blog is more for people to read, to understand it more and, for people who have it, to have something to relate to.
"Because it isn't visible, if you don't tell anyone, they won't know. And people don't realise how much it affects you."
Dan Howarth, head of care at Diabetes UK, said: "Every day we hear from people with type 1 diabetes who say that often, people don't understand their condition and think that they brought it on themselves.
"Captioning a plate of food with #diabetes is not helpful.
"What we need is for people to understand the differences between type 1 and type 2 diabetes which may help to avoid this kind of insensitivity and recognise that all types of diabetes are very serious."
Original post found here:

Wednesday, June 8, 2016

Wait for It: Diabetes News Eagerly Anticipated

This time of year I'm always excited about attending the American Diabetes Association (ADA) Scientific Sessions. This year, they will be held in New Orleans from June 10th through 14th. While I'm not able to tell you any secrets—and, frankly, I don't think I know any—I'm going to talk about what I'm looking forward to learning about and a few things I think will be important.

We know that results from the LEADER trial—the cardiovascular outcomes trial for liraglutide—will be presented on June 13. The headline of these results is that they're positive, but we don't know what cardiovascular outcomes were improved in which patients—basically what this looks like. These results will be very, very important to our understanding of the benefits of GLP-1 receptor agonists on cardiovascular outcomes. I love learning that diabetes drugs also benefit cardiovascular outcomes.

Results of EMPA-REG[1] were reported last fall, and empagliflozin was shown to have significant benefits in terms of reduction in cardiovascular events and overall mortality. But that was just the tip of the iceberg. We have lots to learn; more data about empagliflozin and other SGLT2 inhibitors will be presented at this meeting.

In terms of drugs we have on the market, there are going to be some new twists. Scientists have been studying the combination of a GLP-1 receptor agonist and a basal insulin. They put these together in a pen and give them to patients, gradually increasing the dose. This particular combination has been very effective at reducing A1c's while minimizing side effects. New data on a variety of different combinations should be presented at the ADA meetings.

Because I love technology and devices, the DIaMonD trial is looking at the benefit of continuous glucose monitoring in individuals with type 1 diabetes who are on a multiple daily insulin injection regimen. These are not patients on insulin pumps but patients on injections. I'm hopeful that there will be benefit. I certainly see benefit in the patients I follow in my own clinic.

Finally, there will be lots of information about programs and applications designed to help manage patients with diabetes. There are tools, devices, and apps for your iPhone, and ways to send data back to a clinic, mentor, or a coach to help improve outcomes. But the problem with many of these systems is that they require a lot of feedback. They require time and energy from healthcare providers on the other side of the data. I'll be very interested to see how these applications work in a variety of different settings. I'll try to imagine how they can be useful in my own healthcare settings, where I take care of many patients and want to improve their outcomes—particularly over time. It's easy to get good control over the short haul, but it's maintaining that control over many years that I think is the real challenge for those of us who routinely treat patients with diabetes.

Keep your ears open, listen for diabetes news from June 10 to June 14, and I'm sure you'll hear all sorts of new things. No cure, but there will be a lot to interest you in the coming month. Thank you.